Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells
- PMID: 12464265
- DOI: 10.1016/s0003-9861(02)00522-2
Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells
Abstract
The hepatitis B virus (HBV) is a major cause of human liver disease, including hepatocellular carcinoma (HCC). The prognosis for HCC is largely dependent on the clinicopathological characteristics regarding invasion and metastasis. Enhanced matrix metalloproteinase-9 (MMP-9) expression has been implicated as playing an important role in metastasis and invasion of HCC. However, the relationship between HBV infection and MMP-9 expression in HCC is currently poorly understood. We report here on a study of the levels of MMP-9 and MMP-2 expression in human fetal liver tissue, rat liver tissue, and Chang, HepG2, and Hep3B cells by gelatin zymography. Among these sources, Hep3B cells, which contain the integrated hepatitis B viral genome, continuously secrete the hepatitis B viral surface antigen, and express HBV genomic RNA, expressed high levels of proMMP-9, and a small amount of active MMP-9 was detected in Hep3B cells as assayed by zymography. We investigated the issue of whether HBV infection affects MMP-9 expression, which is known to play an important role in HCC invasion and metastasis. As a first step, human fetal hepatocyte (HFH) and HepG2 (HCC origin, HBV not detected) cells were subjected to infection with HBV, and the resulting infected cells successfully established are hereafter referred to as HFH-T2 and HepG2-HBV. The expression of MMP-9 was upregulated by the infected HBV in HFH-T2 and HepG2-HBV cells, as assayed by zymography, Northern blot, and Western blot analysis, and small amounts of active MMP-9 were detected in HFH-T2 and HepG2-HBV cells as assayed by zymography. The activation of the immature proMMP-9 to the mature MMP-9 could be induced by plasmin treatment. The activation of proMMP-9 was increased to a greater extent with plasmin treatment than without plasmin in HFH-T2 and HepG2-HBV cells but the addition of recombinant TIMP-1 inhibited the activation of proMMP-9. Finally, the addition of plasmin to the invasion assay using Matrigel resulted in an increase in invasiveness of HFH-T2 and HepG2-HBV cells, as well as MMP-9 activation, but the treatment with TIMP-1 inhibited the invasiveness of HFH-T2 and HepG2-HBV cells as well as MMP-9 activation. We conclude from these findings that HBV infection of hepatocytes and HepG2 cells affected the upregulation of MMP-9 expression and MMP-9 activation and, thus, increased the invasion potential by plasmin. To our knowledge, this is a first report showing that an HBV infection is linked to the upregulation of MMP-9 in HCC.
Similar articles
-
Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.Int J Biochem Cell Biol. 2004 Nov;36(11):2293-306. doi: 10.1016/j.biocel.2004.04.022. Int J Biochem Cell Biol. 2004. PMID: 15313474
-
Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.J Gastroenterol Hepatol. 2004 Dec;19(12):1374-87. doi: 10.1111/j.0815-9319.2004.03473.x. J Gastroenterol Hepatol. 2004. PMID: 15610311
-
S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2372-82. Eur Rev Med Pharmacol Sci. 2013. PMID: 24065232 Clinical Trial.
-
Harmonized Autophagy Versus Full-Fledged Hepatitis B Virus: Victorious or Defeated.Viral Immunol. 2019 Oct;32(8):322-334. doi: 10.1089/vim.2019.0042. Epub 2019 Sep 4. Viral Immunol. 2019. PMID: 31483214 Review.
-
Mechanisms of viral hepatitis induced liver injury.Curr Mol Med. 2003 Sep;3(6):537-44. doi: 10.2174/1566524033479591. Curr Mol Med. 2003. PMID: 14527085 Review.
Cited by
-
HBX-mediated migration of HBV-replicating HepG2 cells: insights on development of hepatocellular carcinoma.J Biomed Biotechnol. 2009;2009:930268. doi: 10.1155/2009/930268. Epub 2009 Sep 16. J Biomed Biotechnol. 2009. PMID: 19763277 Free PMC article.
-
Caffeoyl pyrrolidine derivative LY52 inhibits hepatocellular carcinoma invasion via suppressing matrix metalloproteinase-2.Hepatol Int. 2011 Jun;5(2):716-21. doi: 10.1007/s12072-010-9234-y. Epub 2010 Dec 21. Hepatol Int. 2011. PMID: 21484106 Free PMC article.
-
Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.Int J Clin Exp Pathol. 2015 May 1;8(5):4481-91. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191138 Free PMC article.
-
Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism.J Am Heart Assoc. 2016 Sep 30;5(10):e004228. doi: 10.1161/JAHA.116.004228. J Am Heart Assoc. 2016. PMID: 27694328 Free PMC article.
-
Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.Cell Death Dis. 2015 Mar 26;6(3):e1703. doi: 10.1038/cddis.2015.61. Cell Death Dis. 2015. PMID: 25811800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous